Publication:
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.

No Thumbnail Available
Date
2023-07-13
Authors
Authors
TÜRK, HACI MEHMET
Tsuboi M.
Herbst R. S.
John T.
Kato T.
Majem M.
Grohé C.
Wang J.
Goldman J. W.
Lu S.
Journal Title
Journal ISSN
Volume Title
Publisher
Research Projects
Organizational Units
Journal Issue

Metrics

Search on Google Scholar

Abstract
Description
Keywords
Citation
Tsuboi M., Herbst R. S., John T., Kato T., Majem M., Grohé C., Wang J., Goldman J. W., Lu S., Su W., et al., "Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.", The New England journal of medicine, cilt.389, sa.2, ss.137-147, 2023
Page Views

4

File Downloads

0

Sustainable Development Goals